These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8950473)

  • 1. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover.
    French LE; Tschopp J
    Behring Inst Mitt; 1996 Oct; (97):156-60. PubMed ID: 8950473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
    French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
    J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand expression is restricted to nonlymphoid thymic components in situ.
    French LE; Wilson A; Hahne M; Viard I; Tschopp J; MacDonald HR
    J Immunol; 1997 Sep; 159(5):2196-202. PubMed ID: 9278307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Fas ligand in cells of T cell lineage.
    Suda T; Okazaki T; Naito Y; Yokota T; Arai N; Ozaki S; Nakao K; Nagata S
    J Immunol; 1995 Apr; 154(8):3806-13. PubMed ID: 7706720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of CD95 ligand expression: a key element in immune regulation?
    Brunner T; Yoo NJ; Griffith TS; Ferguson TA; Green DR
    Behring Inst Mitt; 1996 Oct; (97):161-74. PubMed ID: 8950474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
    Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
    J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.
    Gienau M; Hartmann KU
    Thymus; 1997; 24(4):279-86. PubMed ID: 9493289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
    Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
    Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J; Liu C; Yang P; Zhou T; Mountz JD
    J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.